Meta Pixel

News and Announcements

How To Determine The Valuation Of Your Startup

  • Published December 14, 2022 6:51AM UTC
  • Publisher Osama Hassan
  • Categories Capital Raising Tips

How do I value my startup? 🤔

Without years of financial data to refer to, founders and investors have to rely on creative and subjective factors. Stone & Chalk have done a great job documenting these factors in their Guide For Startups Raising Capital.

Beyond these factors, SMEs have developed methodologies that provide a mental picture of the average size and price for a particular stage/round relative to other startups and deals in the marketplace.

Here are the 4 valuation methodologies highlighted in the guide:

1) Stage and Berkus Approach

Focuses on the stage of development and growth. The further down the pathway, the lower the risk, and higher the value.

Early stage business concept: $250K-$500K

Lean experiments and MVP built: $500K-$1M

Product Launched/Revenue Management in place: $1.5M-$2M

2) Raise Restricted Approach

Works on the basic assumption that the amount of money startups need to raise and the equity they’re prepared to give up determines the valuation range.

3) Incubators’ Approach

Some incubators apply a standard valuation of $1M or $1.5M for all companies in their program, with their investment of $50-$150K representing a 5-10% equity stake.

4) VC Approach

VCs typically calculate a startup’s value based on a process whereby investors, looking to exit within the first 5-7 years, first estimate an expected exit price for the investment. Then, calculating back to the post-money valuation today, they take into account the time and risk made by the investors to determine an expected return on investment.

Interested to learn other methods of valuing startups.

Click here to view the original Linkedin post.

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now